Literature DB >> 15143986

The development of pulmonary adenocarcinoma in a patient with Job's syndrome, a rare immunodeficiency condition.

Ilhan Oztop1, Binnaz Demirkan, Oktay Tarhan, Hasan Kayahan, Ugur Yilmaz, Aydanur Kargi, Mehmet Alakavuklar.   

Abstract

The hyperimmunoglobulin E (HIE) (Job's) syndrome often has it onset in childhood and is characterized by markedly elevated serum IgE levels, chronic dermatitis and recurrent pyogenic infections. Lymphoid malignancies have most commonly been associated with this syndrome while the first case in the literature of carcinoma associated with HIE syndrome was a squamous cell carcinoma of the vulva, described by Clark et al. in 1998. We observed a male patient with Job's syndrome diagnosed at age three who presented with bone pain and a metastatic epithelial tumor of the bone revealed by biopsy. Diagnostic procedures aimed at detecting the primary site showed multiple mediastinal lymph nodes with lung and liver metastases on computed tomography scans and an extradural spinal metastasis at the upper thoracic level on magnetic resonance imaging. Although the patient refused a bronchoscopic procedure, a diagnosis of pulmonary adenocarcinoma was established on the basis of sputum cytology and the clinical aspects of tumor extent. Intravenous corticosteroids and palliative radiotherapy were given for the spinal metastasis. Palliative chemotherapy could not be started because of the patient's poor performance status as well as nosocomial fungal pneumonia and pseudomonal urogenital infection with bacteremia. Despite the antifungal and broad-spectrum antimicrobial treatments, the patient died of pseudomonal sepsis.

Entities:  

Mesh:

Year:  2004        PMID: 15143986     DOI: 10.1177/030089160409000126

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  12 in total

Review 1.  Hyper-IgE syndrome update.

Authors:  Kathryn J Sowerwine; Steven M Holland; Alexandra F Freeman
Journal:  Ann N Y Acad Sci       Date:  2012-01-23       Impact factor: 5.691

2.  A rare primary immunodeficiency.

Authors:  Poornima Nagaraj; Shobhana Sivathanu; Sowmya Sampath; Nithiyanantham Ramakrishnan
Journal:  BMJ Case Rep       Date:  2014-09-24

3.  Peripheral T-cell lymphoma and Job's syndrome: a rare association.

Authors:  Ibrahim K Onal; Mevlut Kurt; Kadri Altundag; Sercan Aksoy; Murat Dincer; Ibrahim Gullu
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

4.  Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.

Authors:  N C Patel; J L Gallagher; T R Torgerson; A L Gilman
Journal:  J Clin Immunol       Date:  2015-05-12       Impact factor: 8.317

5.  Hemoptysis in a Patient with Elevated Immunoglobulin E.

Authors:  Yael Gernez; Angela Tsuang; Tukisa D Smith; Khurram Shahjehan; Yiqun Hui; Paul J Maglione; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2016-09-29

Review 6.  The hyper-IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

Review 7.  Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

Review 8.  The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

Authors:  Aleksandra Szczawinska-Poplonyk; Zdzislawa Kycler; Barbara Pietrucha; Edyta Heropolitanska-Pliszka; Anna Breborowicz; Karolina Gerreth
Journal:  Orphanet J Rare Dis       Date:  2011-11-15       Impact factor: 4.123

Review 9.  Pulmonary manifestations of primary immunodeficiency disorders in children.

Authors:  Milos Jesenak; Peter Banovcin; Barbora Jesenakova; Eva Babusikova
Journal:  Front Pediatr       Date:  2014-07-25       Impact factor: 3.418

Review 10.  An update on the hyper-IgE syndromes.

Authors:  Patrick F K Yong; Alexandra F Freeman; Karin R Engelhardt; Steven Holland; Jennifer M Puck; Bodo Grimbacher
Journal:  Arthritis Res Ther       Date:  2012-11-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.